Protecting First Responders January 9, 2016 • admin • Keeping our heroes safe from the dangers of chemical exposures. Related News US CIP Patent awarded for use of galantamine as Method of Treating Organophosphorus Poisoning. April 3, 2014 Countervail receives additional $630,000 SBIR Fast Track Phase II grant award for continued development of AverTox® (galantamine) for pre-exposure administration to protect against soman toxicity. August 3, 2015
